Loss of heterozygosity at 17p13.3-ter, distal to TP53, correlates with negative hormonal phenotype in sporadic breast cancer

Oncology Reports

Volumn 14, Issue 2, 2005, Pages 471-474

  Roncuzzi, Laura ^a,b   Brognara, Irene ^a,b   Baiocchi, Daniela ^a   Amadori, Dino ^c   Gasperi Campani, Anna ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^c MORGAGNI PIERANTONI HOSPITAL   (Italy)

Author keywords

Breast cancer; Chromosome 17; Loss of heterozygosity; Oestrogen and progesterone receptors

Indexed keywords

DNA; ESTROGEN RECEPTOR; MICROSATELLITE DNA; PROGESTERONE RECEPTOR; PROTEIN P53;

ARTICLE; BREAST TUMOR; CHROMOSOME 17; FEMALE; GENETICS; HETEROZYGOSITY LOSS; HUMAN; METABOLISM; MIDDLE AGED; PATHOLOGY; PHENOTYPE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; TELOMERE;

BREAST NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 17; DNA, NEOPLASM; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MIDDLE AGED; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TELOMERE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 24744463705     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.14.2.471     Document Type: Article

References (23)

1. Emi M, Yoshimoto M, Sato T, Matsumoto S, Utada Y, Ito I, Minobe K, Iwase T, Katagiri T, Bando K, Akiyama F, HaradaY, Fukino K, Sakamoto G, Matsushima M, lida A, Tada T, Saito H, Miki Y, Kasumi F and NakamuraY: Allelic loss at 1p34, 13q12, 17p13.3 and 17q21.1 correlates with poor postoperative prognosis in breast cancer. Genes Chromosomes Cancer 26: 134-141, 1999. (Pubitemid 29416438)
2. Hoff C, Mollenhauer J, Waldau B, Hamann U and Poustka A: Allelic imbalance and fine mapping of the 17p13.3 subregion in sporadic breast carcinomas. Cancer Genet Cytogenet 129: 145-149, 2001. (Pubitemid 32826307)
3. McHale JC, McKie AB, Tarttelin EE and Inglehearn CF: Expression map of human chromosome region 17p13.3, spanning the RP13 dominant retinitis pigmentosa locus, the Miller-Dieker lissencephaly syndrome (MDLS) region, and a putative tumour suppressor locus. Cytogenet Cell Genet 88: 225-229, 2000. (Pubitemid 30311591)
4. Guan XY, Sham JS, Tai LS, Fang Y, Li H and Liang Q: Evidence for another tumour suppressor gene at 17p13.3 distal to TP53 in hepatocellular carcinoma. Cancer Genet Cytogenet 140: 45-48, 2003. (Pubitemid 36110638)
5. Sarkar C, Chattopadhyay P, Ralte AM, Mahapatra AK and Sinha S: Loss of heterozygosity of a locus in the chromosomal region 17p13.3 is associated with increased cell proliferation in astrocytic tumours. Cancer Genet Cytogenet 144: 156-164, 2003. (Pubitemid 36808963)
6. Tsuchiya E, Tanigami A, Ishikawa Y, Nishida K, Hayashi M, Tokuchi Y, Hashimoto T, Okumura S, Tsuchiya S and Nakagawa K: Three new regions on chromosome 17p13.3 distal to TP53 with possible tumour suppressor gene involvement in lung cancer. Jpn J Cancer Res 91: 589-596, 2000. (Pubitemid 30453785)
7. Sztan M, Papai Z, Szendroi M, Looij M and Olah E: Allelic losses from chromosome 17 in human osteosarcomas. Pathol Oncol Res 3: 115-120, 1997.
8. Schultz DC, Vanderveer L, Berman DB, Hamilton TC, Wong AJ and Godwin AK: Identification of two candidate tumour suppressor genes on chromosome 17p13.3. Cancer Res 56: 1997-2002, 1996. (Pubitemid 26119896)
9. Cornelis RS, van Vliet M, Vos CB, Cleton-Jansen AM, van de Vijver MJ, Peterse JL, Khan PM, Borresen AL, Cornelisse CJ and Devilee P: Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumours without p53 mutations. Cancer Res 54: 4200-4206, 1994. (Pubitemid 24258131)
10. Rood BR, Zhang H, Weitman DM and Cogen PH: Hypermethylation of HIC-1 and 17p allelic loss in medulloblastoma. Cancer Res 62: 3794-3797, 2002. (Pubitemid 34728863)
11. Di Marcotullio L, Ferretti E, De Smaele E, Argenti B, Mincione C, Zazzeroni F, Gallo R, Masuelli L, Napolitano M, Maroder M, Modesti A, Giangaspero F, Screpanti I, Alesse E and Gulino A: REN (KCTD11) is a suppressor of Hedgehog signalling and is deleted in human medulloblastoma. Proc Natl Acad Sci USA 101: 10833-10838, 2004. (Pubitemid 38955828)
12. Morris C, Benjes S, Haataja L, Ledbetter DH, Heisterkamp N and Groffen J: Spatial organisation of ABR and CRK genes on human chromosome band 17p13.3. Oncogene 10: 1009-1011, 1995.
13. World Health Organisation: International Histologic Classification of Breast Tumours. 2nd edition. World Health Organisation, Geneva, 1981.
14. Bloom HJ and Richardson WW: Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11: 359-377, 1957.
15. Gasperi-Campani A, Roncuzzi L, Zoli W and Amadori D: Saporin 6 and lonidamine in primary cell cultures from human breast carcinomas: a synergistic effect. Anticancer Drug Des 12: 91-98, 1997. (Pubitemid 27149694)
16. Hedley DW, Clark GM, Cornelisse CJ, Killander D, Kute T and Merkel D: Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Report of the DNA Cytometry Consensus Conference. Cytometry 14: 482-485, 1993. (Pubitemid 23191956)
17. EORTC Breast Cancer Cooperative Group: Revision of the standards for the assessment of hormone receptors in human breast cancer. Eur J Cancer 16: 1513-1515, 1980.
18. Roncuzzi L, Brognara I, Cocchi S, Zoli W and Gasperi-Campani A: Loss of heterozygosity at pseudoautosomal regions in human breast cancer and association with negative hormonal phenotype. Cancer Genet Cytogenet 135: 173-176, 2002. (Pubitemid 34786769)
19. Knuutila S, Aalto Y, Autio K, Bjorkqvist AM, El-Rifai W, Hemmer S, Huhta T, Kettunen E, Kiuru-Kuhlefelt S, Larramendy ML, Lushnikova T, Monni O, Pere H, Tapper J, Tarkkanen M, Varis A, Wasenius VM, Wolf M and Zhu Y: DNA copy number losses in human neoplasms. Am J Pathol 155: 683-694, 1999. (Pubitemid 29426813)
20. Gasperi-Campani A, Roncuzzi L, Zoli W, Lenzi L, Gruppioni R, Sensi A, Zini N, Farabegoli F and Amadori D: Chromosomal alterations, biological features and in vitro chemosensitivity of SCLC-R1, a new cell line from human metastatic small cell lung carcinoma. Eur J Cancer 34: 724-730, 1998. (Pubitemid 28218951)
21. Liscia DS, Morizio R, Venesio T, Palenzona C, Donadio M and Callahan R: Prognostic significance of loss of heterozygosity at loci on chromosome 17p13.3-ter in sporadic breast cancer is evidence for a putative tumour suppressor gene. Br J Cancer 80: 821-826, 1999. (Pubitemid 29209846)
22. Haga S, Emi M, Hirano A, Utada Y, Kajiwara T, Akiyama F, Sakamoto G, Takahashi K, Tada T, Kasumi F, Miki Y and Nakamura Y: Association of allelic losses at 3p25.1, 13q12 or 17p13.3 with poor prognosis in breast cancers with lymph node metastasis. Jpn J Cancer Res 92: 1199-1206, 2001. (Pubitemid 33133489)
23. Sato T, Tanigami A, Yamakawa K, Akiyama F, Kasumi F, Sakamoto G and Nakamura Y: Allelotype of breast cancer: cumulative allele losses promote tumour progression in primary breast cancer. Cancer Res 50: 7184-7189, 1990.